Good relationship between saliva cotinine kinetics and plasma cotinine kinetics after smoking one cigarette

Regulatory Toxicology and Pharmacology

Volumn 67, Issue 2, 2013, Pages 240-245

  Yuki, Dai ^a   Kikuchi, Akira ^a   Miura, Naoki ^a   Kakehi, Aoi ^a   Onozawa, Masahiro ^a  

^a JAPAN TOBACCO INC   (Japan)

Author keywords

Cotinine; Japanese smokers; Mouth level exposure; Nicotine; Pharmacokinetics; Smoking cigarette

Indexed keywords

COTININE; CYTOCHROME P450 2A6; NICOTINE; TAR;

ADULT; ARTICLE; BLOOD LEVEL; CHEMICAL ANALYSIS; CONTROLLED STUDY; EXPOSURE; FEMALE; HUMAN; JAPANESE; KINETICS; MALE; METABOLISM; MOUTH LEVEL EXPOSURE; PRIORITY JOURNAL; SALIVA LEVEL; SMOKING;

COTININE; JAPANESE SMOKERS; MOUTH LEVEL EXPOSURE; NICOTINE; PHARMACOKINETICS; SMOKING CIGARETTE;

ADULT; COTININE; CROSS-OVER STUDIES; FEMALE; HUMANS; KINETICS; MALE; NICOTINE; SALIVA; SMOKING; TOBACCO PRODUCTS; YOUNG ADULT;

EID: 84886585236     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2013.08.002     Document Type: Article

References (23)

1. Bannon Y.B., Corish J., Corrigan O.I., Devane J.G., Kavanagh M., Mulligan S. Transdermal delivery of nicotine in normal human volunteers: a single dose and multiple dose study. Eur. J. Clin. Pharmacol. 1989, 37:285-290.
2. Benowitz N.L., Hukkanen J., Jacob P. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb. Exp. Pharmacol. 2009, 192:29-60.
3. Benowitz N.L., Perez-Stable E.J., Fong I., Modin G., Herrera B., Jacob P. Ethnic differences in N-glucuronidation of nicotine and cotinine. J. Pharmacol. Exp. Ther. 1999, 291:1196-1203.
4. Curvall M., Elwin C.E., Kazemi-Vala E., Warholm C., Enzell C.R. The pharmacokinetics of cotinine in plasma and saliva from non-smoking healthy volunteers. Eur. J. Clin. Pharmacol. 1990, 38:281-287.
5. Ghosheh O.A., Dwoskin L.P., Miller D.K., Crooks P.A. Accumulation of nicotine and its metabolites in rat brain after intermittent or continuous peripheral administration of [2'-(14)C]nicotine. Drug Metab. Dispos. 2001, 29:645-651.
6. Green J.T., Evans B.K., Rhodes J., Thomas G.A., Ranshaw C., Feyerabend C., Russell M.A. An oral formulation of nicotine for release and absorption in the colon: its development and pharmacokinetics. Br. J. Clin. Pharmacol. 1999, 48:485-493.
7. Crooks P.A. Chemical properties of nicotine and other tobacco-related compounds. Analytical determination of nicotine and related compounds and their metabolites 1999, 69-147. Elsevier, Oxford. J.W. Gorrod, P. Jacob (Eds.).
8. Hatsukami, D.K., Hecht, S.S., Hennrikus, D.J., Joseph, A.M., Pentel, P.R., 2003. Biomarkers of tobacco exposure or harm: application to clinical and epidemiological studies. 25-26 October 2001, Minneapolis, Minnesota. Nicotine Tob Res. 5, 387-96.
9. Hukkanen J., Jacob P., Benowitz N.L. Metabolism and disposition kinetics of nicotine. Pharmacol. Rev. 2005, 57:79-115.
10. ISO 3308, 2000. Routine analytical cigarette-smoking machine - definitions and standard conditions.
11. ISO 4387, 2000. Cigarettes - Determination of total and nicotine-free dry particulate matter using a routine analytical smoking machine.
12. Jarvis M., Tunstall-Pedoe H., Feyerabend C., Vesey C., Salloojee Y. Biochemical markers of smoke absorption and self reported exposure to passive smoking. J. Epidemiol. Community Health 1984, 38:335-339.
13. Jarvis M.J., Primatesta P., Erens B., Feyerabend C., Bryant A. Measuring nicotine intake in population surveys: comparability of saliva cotinine and plasma cotinine estimates. Nicotine Tob. Res. 2003, 5:349-355.
14. Karin M.H., Douwe B., Jan Z., Robert A.A. Saliva as an analytical tool in toxicology. Int. J. Drug Test. 1999, 1:1-36.
15. Luck W., Nau H. Nicotine and cotinine concentrations in serum and milk of nursing smokers. Br. J. Clin. Pharmacol. 1984, 18:9-15.
16. Nair M.K., Chetty D.J., Ho H., Chien Y.W. Biomembrane permeation of nicotine: mechanistic studies with porcine mucosae and skin. J. Pharm. Sci. 1997, 86:257-262.
17. Nakajima M., Fukami T., Yamanaka H., Higashi E., Sakai H., Yoshida R., Kwon J.T., McLeod H.L., Yokoi T. Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations. Clin. Pharmacol. Ther. 2006, 80:282-297.
18. Parzynski C.S., Jaszyna-Gasior M., Franken F.H., Moolchan E.T. Measuring nicotine intake among highly-dependent adolescent smokers: comparability of saliva and plasma cotinine concentrations. Pharmacol. Biochem. Behav. 2008, 89:145-149.
19. Rose J.E., Levin E.D., Benowitz N. Saliva nicotine as an index of plasma levels in nicotine skin patch users. Ther. Drug Monit. 1993, 15:431-435.
20. Sobue S., Sekiguchi K., Kikkawa H., Akasaki M., Irie S. Comparison of nicotine pharmacokinetics in healthy Japanese male smokers following application of the transdermal nicotine patch and cigarette smoking. Biol. Pharm. Bull. 2006, 29:1068-1073.
21. Biochemical verification of tobacco use and cessation. Nicotine Tob. Res. 2002, 4:149-159. SRNT Subcommittee on Biochemical Verification.
22. Yoshida R., Nakajima M., Watanabe Y., Kwon J.T., Yokoi T. Genetic polymorphisms in human CYP2A6 gene causing impaired nicotine metabolism. Br. J. Clin. Pharmacol. 2002, 54:511-517.
23. Yun H.Y., Seo J.W., Choi J.E., Baek I.H., Kang W., Kwon K.I. Effects of smoking on the pharmacokinetics and pharmacodynamics of a nicotine patch. Biopharm. Drug Dispos. 2008, 29:521-528.